oxybutynin has been researched along with Allergic Conjunctivitis in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Senti, G | 1 |
| von Moos, S | 1 |
| Tay, F | 1 |
| Graf, N | 1 |
| Johansen, P | 1 |
| Kündig, TM | 1 |
1 trial available for oxybutynin and Allergic Conjunctivitis
| Article | Year |
|---|---|
Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials.
Topics: Adolescent; Adult; Aged; Conjunctivitis, Allergic; Desensitization, Immunologic; Double-Blind Method | 2015 |